50 results on '"WAGNON J"'
Search Results
2. Etiology of a genetically complex seizure disorder in Celf4 mutant mice
3. Chapter 15 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands
4. Key Amino Acids Located within the Transmembrane Domains 5 and 7 Account for the Pharmacological Specificity of the Human V1b Vasopressin Receptor
5. The Discovery of Novel Vasopressin V1b Receptor Ligands for Pharmacological, Functional and Structural Investigations
6. Biochemical and Pharmacological Properties of SR 49059, a New, Potent, Nonpeptide Antagonist of Rat and Human Vasopressin V (1a) Receptors
7. Chapter 15 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands
8. Long‐term evaluation of respiratory status after esophageal atresia repair
9. P328 Multiple short-term dose intensifications are effective in Crohn's disease patients treated with adalimumab
10. Review of respiratory impact in oesophageal atresia
11. Devenir d'une cohorte de nouveau-nés atteints de hernie de coupole diaphragmatique congénitale pris en charge au CHU de Rennes entre décembre 1999 et mars 2005
12. Allaitement maternel et végétalisme
13. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
14. The Discovery of Novel Vasopressin V1b Receptor Ligands for Pharmacological, Functional and Structural Investigations.
15. Conformational analysis of pepstatin and related renin inhibitors by 400 MHz 1H n.m.r. spectroscopy.
16. SOME ASPECTS OF CONCERTED REACTIONS IN ORGANOMETALLIC SYSTEMS.
17. CONFORMATIONAL PREFERENCES AND SELF-ASSOCIATION MODES OF 2 DIASTEREOMERIC STATINE DERIVATIVES
18. ChemInform Abstract: (2PI+6PI)CYCLOADDITION REACTIONS BETWEEN LIGANDS COORDINATED TO AN IRON ATOM
19. Conformational analysis of pepstatin and related renin inhibitors by 400 MHz 1H n.m.r. spectroscopy
20. [2.pi. + 6.pi.] Cycloaddition reactions between ligands coordinated to an iron atom
21. ChemInform Abstract: ASYMMETRISCHE CYANO‐CUPRATE ALS SUBSTITUTIONS‐ UND ADDITIONSREAGENTIEN
22. The backbone rearrangement of androst-5-ene-3β,17β-diol: a chemical proof
23. The backbone rearrangement of cholesterol: a chemical proof
24. ChemInform Abstract: SKELETT-UMLAGERUNG DES CHOLESTERINS, EINE CHEMISCHE UNTERSUCHUNG
25. Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009
26. The backbone rearrangement of cholesterol: a chemical proof.
27. Seizures Cause Prolonged Impairment of Ventilation, CO 2 Chemoreception and Thermoregulation.
28. The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.
29. Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.
30. A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease.
31. Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.
32. Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.
33. Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand.
34. [Breastfeeding and vegan diet].
35. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
36. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
37. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
38. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
39. [The treatment of static metatarsalgia using osteotomy of the base of the metatarsus, and its potential association with the Hohmann technique for treatment of hallux valgus].
40. [Treatment of fractures of the wrist by dynamic fixation].
41. [Leg fractures: choice of treatment according to type of fracture].
42. Conformational preferences and self-association modes of two diastereomeric statine derivatives.
43. Renin inhibitors. Free-Wilson and correlation analysis of the inhibitory potency of a series of pepstatin analogues on plasma renin.
44. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
45. [Our current concept of the treatment of wrist fractures by compression-extension in the adult].
46. [Personal experience with intermediate prostheses. Apropos of 276 cases].
47. [Colonothoracic fistulas: presentation of 2 cases].
48. [Place of primary nerve repair using epiperineural sutures. Apropos of 22 cases of median nerve injuries].
49. [Management of fractures of the base of the first metacarpal bone using an external mini-brace. Apropos of a preliminary series of 14 cases].
50. [Stereochemistry. XXXV. Fluorinated steroids. VI. Skeletal rearrangement of 5-androstene 3-beta, 17-beta diol].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.